GlassScriptPhysician profile
Anita Holtz
NPI 1548452675
$10,573.17
in general payments reported to CMS, 2019-2025
30 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $1,095 · 2021: $399 · 2022: $578 · 2023: $6,983 · 2024: $605 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $1,766 · Travel and Lodging: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $1,765.61 |
| Travel and Lodging | $478.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,478.51 | 2023 | Da Vinci Surgical System |
| Genentech, INC. | $1,000.00 | 2020 | |
| Glaxosmithkline, LLC. | $955.96 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $389.47 | 2020-2025 | Arikayce |
| Philips North America LLC | $290.81 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $232.72 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Genzyme Corporation | $187.95 | 2024-2025 | |
| Grifols USA, LLC | $102.63 | 2021-2024 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.85 | 2020-2022 | |
| Electromed, INC. | $81.36 | 2021-2022 | |
| Mylan Specialty L.P. | $78.93 | 2021-2024 | Yupelri |
| Abbvie INC. | $77.11 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $61.24 | 2024 | Dupixent |
| Gilead Sciences, INC. | $57.54 | 2023 | |
| Janssen Pharmaceuticals, INC | $51.07 | 2022-2024 | Xarelto |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $46.39 | 2021-2022 | |
| Ambu INC. | $44.93 | 2023 | |
| Edwards Lifesciences Corporation | $36.91 | 2022 | |
| Inari Medical, INC. | $35.83 | 2022 | |
| Amgen INC. | $35.75 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $33.15 | 2023-2025 | Inspire |
| Boston Scientific Corporation | $30.85 | 2022 | |
| Baxter Healthcare | $27.57 | 2025 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $26.75 | 2025 | Tyvaso |
| Nabriva Therapeutics, Plc | $25.31 | 2022 | |
| Aimmune Therapeutics, INC. | $24.44 | 2025 | Zenpep |
| Ceribell, INC. | $24.28 | 2025 | Pocket Eeg Device |
| Ethicon INC. | $17.47 | 2025 | Monarch Platform |
| Olympus America INC. | $15.04 | 2021 | |
| Veran Medical Technologies, INC. | $5.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Holtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.